Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

The Assignment of American Society of Anesthesiologists Physical Status Classification for Adult Polytrauma Patients: Results From a Survey and Future Considerations.

Kuza CM, Hatzakis G, Nahmias JT.

Anesth Analg. 2017 Sep 7. doi: 10.1213/ANE.0000000000002450. [Epub ahead of print]

PMID:
28891913
2.

Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in Canada.

Samji H, Taha TE, Moore D, Burchell AN, Cescon A, Cooper C, Raboud JM, Klein MB, Loutfy MR, Machouf N, Tsoukas CM, Montaner JS, Hogg RS; Canadian Observational Cohort (CANOC) Collaboration.

HIV Med. 2015 Feb;16(2):76-87. doi: 10.1111/hiv.12173. Epub 2014 Sep 1.

3.

Clinical impact of altered T-cell homeostasis in treated HIV patients enrolled in a large observational cohort.

Ndumbi P, Gillis J, Raboud JM, Cooper C, Hogg RS, Montaner JS, Burchell AN, Loutfy MR, Machouf N, Klein MB, Tsoukas CM; Canadian Observational Cohort (CANOC) collaboration.

AIDS. 2013 Nov 28;27(18):2863-72. doi: 10.1097/01.aids.0000432471.84497.bc.

PMID:
25119689
4.

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy.

Tsoukas C, Gilbert L, Lewis T, Hatzakis G, Falcon R, Mrus J.

ISRN AIDS. 2013 Dec 12;2013:358294. doi: 10.1155/2013/358294. eCollection 2013.

5.

Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.

Ndumbi P, Gillis J, Raboud J, Cooper C, Hogg RS, Montaner JS, Burchell AN, Loutfy MR, Machouf N, Klein MB, Tsoukas C; Canadian Observational Cohort (CANOC) Collaboration.

HIV Med. 2014 Mar;15(3):153-64. doi: 10.1111/hiv.12096. Epub 2013 Oct 31.

6.

Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.

Leung V, Gillis J, Raboud J, Cooper C, Hogg RS, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Klein MB; CANOC Collaboration.

PLoS One. 2013 Oct 30;8(10):e77665. doi: 10.1371/journal.pone.0077665. eCollection 2013.

7.

Impact of the Data Collection on Adverse Events of Anti-HIV Drugs cohort study on abacavir prescription among treatment-naive, HIV-infected patients in Canada.

Antoniou T, Gillis J, Loutfy MR, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Raboud JM; Canadian Observational Cohort (CANOC) collaboration.

J Int Assoc Provid AIDS Care. 2014 Mar-Apr;13(2):153-9. doi: 10.1177/2325957413495565. Epub 2013 Jul 25.

PMID:
23887923
8.

Relationship of chronic hepatitis C infection to rates of AIDS-defining illnesses in a Canadian cohort of HIV seropositive individuals receiving highly active antiretroviral therapy.

Raboud J, Anema A, Su D, Klein MB, Zakaryan A, Swan T, Palmer A, Hosein S, Loutfy MR, Machouf N, Montaner JS, Rourke SB, Tsoukas C, Hogg RS, Cooper C; Canadian Observational Cohort (CANOC) Collaboration.

HIV Clin Trials. 2012 Mar-Apr;13(2):90-102. doi: 10.1310/hct1302-90.

PMID:
22510356
9.

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis.

Grennan JT, Loutfy MR, Su D, Harrigan PR, Cooper C, Klein M, Machouf N, Montaner JS, Rourke S, Tsoukas C, Hogg B, Raboud J; CANOC Collaboration.

J Infect Dis. 2012 Apr 15;205(8):1230-8. doi: 10.1093/infdis/jis104.

10.

Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.

Tan DH, Chan K, Raboud J, Cooper C, Montaner JS, Walmsley S, Hogg RS, Klein MB, Machouf N, Rourke SB, Tsoukas C, Loutfy MR; CANOC Collaboration.

J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):38-46. doi: 10.1097/QAI.0b013e3182282cfc.

PMID:
21709570
11.

A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.

Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, Walmsley SL, Smieja M, Bayoumi A, Mills E, Hogg RS; CANOC Collaboration.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):451-9.

PMID:
21105259
12.

Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort.

Cescon AM, Cooper C, Chan K, Palmer AK, Klein MB, Machouf N, Loutfy MR, Raboud J, Rachlis A, Ding E, Lima VD, Montaner JS, Rourke SB, Smieja M, Tsoukas C, Hogg RS; CANOC Collaboration.

HIV Med. 2011 Jul;12(6):352-60. doi: 10.1111/j.1468-1293.2010.00890.x. Epub 2010 Nov 8.

13.

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.

Raboud JM, Loutfy MR, Su D, Bayoumi AM, Klein MB, Cooper C, Machouf N, Rourke S, Walmsley S, Rachlis A, Harrigan PR, Smieja M, Tsoukas C, Montaner JS, Hogg RS; CANOC Collaboration.

BMC Infect Dis. 2010 Feb 25;10:40. doi: 10.1186/1471-2334-10-40.

14.

Cohort profile: the Canadian Observational Cohort collaboration.

Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, Machouf N, Montaner J, Rourke SB, Smieja M, Tsoukas C, Yip B, Milan D, Hogg RS; CANOC Collaboration.

Int J Epidemiol. 2011 Feb;40(1):25-32. doi: 10.1093/ije/dyp393. Epub 2010 Feb 15. No abstract available.

PMID:
20157000
15.

Noninvasive monitoring of the autonomic nervous system and hemodynamics of patients with blunt and penetrating trauma.

Colombo J, Shoemaker WC, Belzberg H, Hatzakis G, Fathizadeh P, Demetriades D.

J Trauma. 2008 Dec;65(6):1364-73. doi: 10.1097/TA.0b013e31818cc307.

PMID:
19077628
16.

Risk factors for extreme events in infants hospitalized for apparent life-threatening events.

Al-Kindy HA, Gélinas JF, Hatzakis G, Côté A.

J Pediatr. 2009 Mar;154(3):332-7, 337.e1-2. doi: 10.1016/j.jpeds.2008.08.051. Epub 2008 Oct 31.

PMID:
18950797
17.

Disseminated intravascular coagulation score is associated with mortality for children with shock.

Khemani RG, Bart RD, Alonzo TA, Hatzakis G, Hallam D, Newth CJ.

Intensive Care Med. 2009 Feb;35(2):327-33. doi: 10.1007/s00134-008-1280-8. Epub 2008 Sep 18.

PMID:
18802683
18.

Weaning children from mechanical ventilation with a computer-driven system (closed-loop protocol): a pilot study.

Jouvet P, Farges C, Hatzakis G, Monir A, Lesage F, Dupic L, Brochard L, Hubert P.

Pediatr Crit Care Med. 2007 Sep;8(5):425-32.

PMID:
17693913
19.

Sudden infant deaths in sitting devices.

Côté A, Bairam A, Deschenes M, Hatzakis G.

Arch Dis Child. 2008 May;93(5):384-9. Epub 2007 Jul 19.

PMID:
17641002
20.

Acceptable respiratory physiologic limits for children during weaning from mechanical ventilation.

Santschi M, Gauvin F, Hatzakis G, Lacroix J, Jouvet P.

Intensive Care Med. 2007 Feb;33(2):319-25. Epub 2006 Oct 25.

PMID:
17063358

Supplemental Content

Loading ...
Support Center